Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer
Author(s) -
Bruna Maria Röesler,
Sandra Cecı́lia Botelho Costa,
José Murilo Robilotta Zeitune
Publication year - 2012
Publication title -
isrn gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 2090-4401
pISSN - 2090-4398
DOI - 10.5402/2012/935410
Subject(s) - helicobacter pylori , cancer , stomach , carcinogenesis , immune system , gastric mucosa , medicine , gastroenterology , carcinogen , immunology , biology , genetics
Helicobacter pylori is the most important carcinogen for gastric adenocarcinoma. Bacterial virulence factors are essential players in modulating the immune response involved in the initiation of carcinogenesis in the stomach; host genetic factors contribute to the regulation of the inflammatory response and to the aggravation of mucosal damage. In terms of environmental factors, salt intake and smoking contribute to the development of lesions. Various therapeutic schemes are proposed to eradicate H. pylori infection, which could potentially prevent gastric cancer, offering the greatest benefit if performed before premalignant changes of the gastric mucosa have occurred.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom